共 38 条
[11]
Hsn CH., Patel S., Factors influencing calcitriol metabolism in renal failure., Kidney International, 37, pp. 44-50, (1990)
[12]
Giovannetti S., Barsotti G., Dialysis of methylguanidine., Kidney Int, 6, pp. 177-183, (1974)
[13]
Boumendil-Podevin EF., Podevin RA., Richet G., Uricosuric agents in uremic sera. Identification of indoxyl sulfate and hippuric acid., Journal of Clinical Investigation, 55, pp. 1142-1152, (1975)
[14]
Niwa T., Yazawa T., Kodama T., Uehara Y., Maeda K., Yamada K., Efficient removal of albumin‐bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis., Nephron, 56, pp. 241-245, (1990)
[15]
Vanholder R., Van Landschoot N., De Smet R., Schoots A., Ringoir S., Drug protein binding in chronic renal failure: Evaluation of nine drugs., Kidney Int, 33, pp. 996-1004, (1988)
[16]
Vanholder R., Schoots A., Ringoir S., Hippuric acid as a marker, Uremic toxins, pp. 59-67, (1981)
[17]
Vanholder R., De Smet R., Ringoir S., Assessment of urea and other uremic markers for quantification of dialysis efficacy., Clin Chem, 38, pp. 1429-1436, (1992)
[18]
Farrell PC., Gotch FA., Peters JH., Berridge BJ., Lam M., Binding of hippurate in normal plasma and in uremic plasma pre‐ and postdialysis., Nephron, 20, pp. 40-46, (1978)
[19]
Abiko T., Onodera T., Sekino HA., A peptide isolated from the hemodialysate of a uremic patient with immunodeficiency inhibits lymphocyte stimulation., J Appl Biochem, 3, pp. 562-569, (1981)
[20]
Malachi T., Bogin E., Gafter U., Levi L., Parathyroid hormone effect on the fragility of human young and old red blood cells in uremia., Nephron, 42, pp. 52-57, (1986)